CalciMedica (CALC) chief business officer reports open-market stock purchase
Rhea-AI Filing Summary
CalciMedica, Inc. director, chief business officer, and 10% owner Eric W. Roberts reported an open-market purchase of 3,508 shares of common stock on August 21, 2025 at a weighted average price of $2.7928 per share. The purchased shares are held indirectly through an FMTC Custodian Roth IRA for his benefit, which now holds 60,907 shares after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 3,508 shares
Net Buy
7 txns
Insider
Roberts Eric W
Role
CHIEF BUSINESS OFFICER
Bought
3,508 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 3,508 | $2.7928 | $10K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 60,907 shares (Indirect, By FMTC Custodian - Roth IRA FBO Eric W. Roberts);
Common Stock — 179,706 shares (Direct);
Common Stock — 49,894 shares (Indirect, By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA);
Common Stock — 10,661 shares (Indirect, By IRA Financial Trust Company CFBO Eric W. Roberts);
Common Stock — 356,989 shares (Indirect, By Valence Investments SPV IV, LLC);
Common Stock — 66,228 shares (Indirect, By Valence Investments SPV V, LLC);
Common Stock — 316,109 shares (Indirect, By Valence Investments SPV VI, LLC)
Footnotes (1)
- F1. The weighted average purchase price for the transaction reported was $2.7928, and the range of prices were between $2.75 and $2.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Eric W. Roberts report for CalciMedica (CALC)?
Eric W. Roberts reported buying 3,508 CalciMedica common shares in an open-market transaction. The trade occurred on August 21, 2025 at a weighted average price of $2.7928 per share, according to his Form 4 filing.
What is Eric W. Roberts’ role at CalciMedica (CALC)?
Eric W. Roberts is a director, chief business officer, and a 10% owner of CalciMedica, Inc. These roles are disclosed in the Form 4, which also reports his recent indirect purchase of common stock through a Roth IRA account.